OTCM
RMSL
Market cap2mUSD
Oct 08, Last price
0.00USD
1D
0.00%
1Q
-34.07%
IPO
-99.80%
Name
REMSleep Holdings Inc
Chart & performance
P/E
—
P/S
152.02
EPS
—
Div yield, %
—
Shrs. gr., 5y
29.45%
Rev. gr., 5y
%
Revenues
17k
-85.73%
Net income
-3.02t
L+280,176,932.03%
CFO
-502.83b
L+73,614,400.69%
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
REMSleep Holdings, Inc. is an enterprise globally focused on crafting and providing solutions for individuals afflicted with sleep apnea. Among its key offerings is the DeltaWave CPAP interface device, specifically engineered to aid in the treatment of patients suffering from this condition. The company caters to a broad spectrum of clients, including home healthcare providers, independent sleep clinics, direct consumers, medical practitioners, group medical organizations, hospitals, and various professional medical associations. Its corporate headquarters are situated in Tampa, Florida.
Key people
Thomas Wood
Chief Executive Officer, Director · since 2015
Jonathan Lane
Chief Technology Officer, Vice President · since 2019
Legal address
C/O The Corporation Trust Company of Nevada
701 South Carson Street
Suite 200
Carson City, NV 89701
US
701 South Carson Street
Suite 200
Carson City, NV 89701
US
Headquarters
C/O The Corporation Trust Company of Nevada
311 South Division Street
Carson City, NV 89703
US
311 South Division Street
Carson City, NV 89703
US
Previous name
Kat Gold Holding, Corp.
Previous name
Obicom, Inc.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||